"Peer review encourages inclusion of new ideas and points of view that all together supports high quality research and ultimately improves patient care" - Mei Lin Bissonette an #ASNCJASN's top reviewer of 2025 @bcrenalpath.bsky.social

In a qualitative study of veterans with CKD, this #ASNCJASN research shares participants' experience and perspectives with nutrition. kidney.pub/CJASN0800#ASNCJASN

Even mild baseline CKD is associated with higher risk of Long COVID among patients with acute SARS-CoV-2 infection. Additionally, among those with baseline CKD, Long COVID is associated with faster kidney function decline. Read more in #ASNCJASN kidney.pub/CJASN0773#ASNCJASN

New in #ASNJASN and at #Hypertension25: In a randomized, double-blind, placebo-controlled trial, Baxdrostat reduced systolic blood pressure in patients with CKD and uncontrolled hypertension. Read more about its safety and efficacy in patients with CKD here: kidney.pub/JASN0849

Medicare reimbursement of dialysis care began in 1973. The improvement of dialysis care moving forward depends on understanding the history, challenges, and opportunities between US healthcare policy and treatment coverage. #ASNKidneyNews kidney.pub/KN1709-09#ASNKidneyNews

Dennis Brown is one of #ASNJASN's top reviewers of 2025. He says reviewing "affords me the opportunity to contribute directly to the reciprocal quality control process necessary for the scientific ecosystem to function as a trustworthy enterprise, and to learn about the latest advances in my field."

How does age impact the onset of hypertension and subsequent incidence of CKD? This #ASNKidney360 study dives deep to evaluate: kidney.pub/KID0872#ASNKidney360

In a new #ASNJASN article, epidermal growth factor receptor (EGFR) activation stimulates SOX9 expression in injured renal proximal tubule epithelial cells following acute kidney injury. kidney.pub/JASN0830#ASNJASN#BasicResearcj

New in #ASNJASN: This #perspective dives deep on the hyperfiltration paradigm, suggesting the integration of nephro-podometrics to enrich its explanatory power for CKD. kidney.pub/JASN0852

Autumn leaves, birch bark, and the swirling currents of this month's Creative Cortex. Check out this kidney-inspired artwork in #ASNKidneyNews: kidney.pub/KN1709-08#ASNKidneyNews:

Can genetic factors act as determinants of salt sensitivity and modify the effect of salt intake on CKD? This #ASNCJASN study of the UK Biobank investigates: kidney.pub/CJASN0793#ASNCJASN

Is it time for nephrologists to re-examine the obesity paradox? This #ASNKidneyNews article details recent studies on GLP-1 receptor agonists and what they mean for patients undergoing dialysis. Read more at: kidney.pub/KN1709-07#ASNKidneyNews @littlebiggloms.bsky.social

This #ASNKidney360 study finds that the Furst equation helps identify patients at risk of fluid restriction failure in SIAD, although its predictive performance is limited. kidney.pub/KID0912#ASNKidney360

🚨 Just released: ASN Kidney Health Guidance on Potassium & Phosphorus Food Additives. Learn to understand risk differences, manage hyperkalemia and CKD-MBD risk, identify foods with additives, and target interventions to improve care for people living with kidney diseases. 🔗kidney.pub/JASN0873

In patients post-kidney transplantation, vitamin D insufficiency is associated with higher risk of death-censored graft failure and infection-related mortality. Read more in #ASNKidney360: kidney.pub/KID0942#ASNKidney360:

New in #ASNCJASN published simultaneously with #EASD2025 : "Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE" Read more: 🔗 kidney.pub/CJASN0865#ASNCJASN#EASD2025

Nephrology is catching up to other imaging-heavy specialties and is embracing a flood of AI applications. Collaboration and communication remain key to implementation. #ASNKidneyNews: kidney.pub/KN1709-06#ASNKidneyNews:

Foot Process Effacement (FPE) could serve as a valuable marker for assessing the risk of disease progression across various kidney pathologies. Read more in #ASNKidney360: kidney.pub/KID0894#ASNKidney360: @ashunephro.bsky.social @sophieclaudel.bsky.social

Peer review is vital to publishing high-quality, valid research. JASN wants to recognize the top reviewers of 2025: Drs. Tushar Chopra, Mirela Dobre, Valerie Luyckx, Erik Lum, and Satoshi Minami. Over the next few weeks, we'll share their thoughts on peer review. #PRW2025

Frailty is common in patients with CKD. This #ASNCJASN article finds most measures of frailty, regardless of definition used, were associated with higher risk of mortality, hospitalizations, and ER visits. kidney.pub/CJASN0797#ASNCJASN

The second installment of the proceedings of the University of Alabama at Birmingham Continuous Renal Replacement Therapy Academy is now live in #ASNKidney360. Read more about transitions of care in acute RRT: kidney.pub/KID0951#ASNKidney360.

Peer review week continues: CJASN recognizes the top reviewers of 2025: Drs. Cynthia Nast, Edwina Brown, Csaba Kovesdy, Mei Lin Bissonnette, and Keiichi Sumida. Each day, we'll share their thoughts on peer review. #PRW2025 @edwinabrown-pd.bsky.social @bcrenalpath.bsky.social

Primary hyperoxaluria (PH) comprises a rare group of genetic disorders leading to the overproduction of oxalate. Could new RNA inhibitor drugs be the answer? Read more In #ASNKidneyNews: kidney.pub/KN1709-05#ASNKidneyNews:

Peer review is vital to publishing high-quality, valid research. JASN wants to recognize the top reviewers of 2025: Drs. Dennis Brown, Ladan Golestaneh, Monica Suet Ying Ng, Navdeep Tangri, and Nicola M. Thomas. Over the next few weeks, we'll share their thoughts on peer review. #PeerReviewWeek

Lupus nephritis is seeing more enriching immunotherapies, but important unmet needs remain. In this #ASNCJASN article: authors detail how to focus on histological signs of immunological activity triggering immunotherapy vs signs of kidney injury requiring care for CKD. kidney.pub/CJASN0858

This review in #ASNKidney360 details the actions and interplay between the mineralocorticoid system, inflammation, hypertension, and kidney disease. Read more: kidney.pub/KID0929#ASNKidney360

#Perspective: limitations of current clinical bone turnover assessment in CKD highlight the unmet need for alternative, non-invasive approaches that are reliable and available. Time-lapse HR-pQCT has this potential. #ASNJASN kidney.pub/JASN0848#Perspective:#ASNJASN

Join #ASNKidneyNews in celebrating the legacy of Marianne Leenaerts, cofounder and CEO of the Primary Aldosteronism Foundation and public health advocate. Kidney.pub/KN1709-04#ASNKidneyNews

In this #ASNCJASN review, authors detail patient engagement in the design and conduct of the HOPE consortium trial to reduce pain and opioid use in hemodialysis. Read more: kidney.pub/CJASN0866#ASNCJASN

The "One Big Beautiful Bill Act" may have sweeping impact on kidney disease care and coverage including: - Medicaid cuts - Caps on federal student loans - Changes to the ACA Marketplace enrollment process Read more: kidney.pub/KN1709-03 #ASNKidneyNews

Podcast Alert 🚨: In severe and late-stage uremia, hemodialysis is often the preferred modality on rationale that it can address complications within a few hours, but what about PD? Listen to the discussion of this recent #ASNKidney360 article 🔗: kidney.pub/KPOD0863

New in #ASNJASN: dysregulated bone marrow contributes to glomerular injury through soluble factors. This study suggests that bone marrow dysfunction could be a central upstream driver of CKD. Read more: kidney.pub/JASN0828#ASNJASN:#BasicResearch @arianaalcantar.bsky.social

What are the most important risk factors for suboptimal dialysis initiation? In #ASNKidney360, this article investigates within a prospective cohort study. Read more: kidney.pub/KID0895#ASNKidney360, @hswapnil.medsky.social @sbrimble.bsky.social

New in #ASNJASN: How the evolving landscape of non-invasive diagnostic tools to detect kidney allograft rejection present opportunities for early intervention. kidney.pub/JASN0842#ASNJASN:

Female volunteers tend to be living kidney donors at higher rates than male volunteers. This #ASNKidney360 article and accompanying podcast investigates potential underlying reasons. Read here 📖: kidney.pub/KID0581 or listen to the podcast 🎤: kidney.pub/KPOD0581

Starting statins while in dialysis treatment is controversial. This #ASNKidneyNews article explores clinical guidelines, a lack of clinical trials, and how to proceed as evidence evolves: kidney.pub/KN1709-02#ASNKidneyNews drtariqshafi.bsky.social

In a cohort of patients undergoing hemodialysis, this #ASNJASN research analyzed circulating mycobiota signatures and highlights their potential as prognostic biomarkers. kidney.pub/JASN0829#ASNJASN

New Podcast: Drs. Levin and Wernerson discuss the findings from their study, "Transcriptomic Patterns in Adult and Pediatric Patients with IgA Nephropathy or IgA Vasculitis with Nephropathy." Listen here: kidney.pub/JPOD0787 #ASNJASN

The September issue of CJASN is now available online! Topics covered this month include: - Fall Risk and Hemodialysis - Nurse Assisted PD - and more Check out the issue here: kidney.pub/CJASN-0925 #ASNCJASN Cover by Aierken et al.

What is the role of genetic testing in atypical hemolytic uremic syndrome? This #ASNCJASN Kidney Case Conference shares perspective: kidney.pub/CJASN0854

New #BasicResearch in #ASNJASN used a murine model, imaging mass spectrometry, and a metabolome analysis to investigate the metabolic pathway that characterizes tertiary lymphoid structures. Read more: kidney.pub/JASN0825#BasicResearch

The September issue of Kidney News is online! Topics include: - Advancing AI applications for kidney diseases - What the "One Big Beautiful Bill Act" means for kidney care + coverage - Insights on IgA nephropathy Explore the issue: kidney.pub/KN1709-01 #ASNKidneyNews @kdjhaveri.bsky.social

Now in #ASNJASN: A validation study of the Klinrisk machine learning model for CKD progression in a large representative US population finds the model to be accurate across commercial, Medicare, and Medicaid populations. kidney.pub/JASN0817#ASNJASN:

How does the timing of AKI during ECMO treatment impact hospital survival? This #ASNKidney360 article shows that sever AKI is associated with reduced hospital survival, whether it occurs before or during ECMO. kidney.pub/KID0920#ASNKidney360

Genetic sex is an important determinant of kidney injury and repair, with female kidneys typically exhibiting greater resilience to AKI. This #ASNJASN research examines how augmenting Gsta2 expression in male proximal tubule cells affects resistance to IRI. kidney.pub/JASN0840#ASNJASN

Kidney dysfunction was diagnosed at 5-months postpartum in 12% of patients who had gestational diabetes mellitus. Read more in #ASNCJASN kidney.pub/CJASN0802#ASNCJASN

In a mouse model of IgA nephropathy, this #ASNJASN original research finds that FcγRIIB deficiency in macrophages and dendritic cells led to increased albuminuria, kidney dysfunction, and kidney injury. Read more: kidney.pub/JASN0835#ASNJASN#BasicResearch

New in #ASNJASN and at #Hypertension25: In a randomized, double-blind, placebo-controlled trial, Baxdrostat reduced systolic blood pressure in patients with CKD and uncontrolled hypertension. Read more about its safety and efficacy in patients with CKD here: kidney.pub/JASN0849

Calling all nephrology artists! Creative Cortex is a new article type in Kidney News showcasing the artistic side of nephrology through your submissions of original, kidney-related artwork. Accepting submissions now: kidney.pub/KNartwork. #ASNKidneyNews

This patient perspective offers first-hand experiences using electronic patient-reported outcome measures (ePROM), commenting on how it is easy to use, insightful, and quick to evaluate. Read more in #ASNCJASN: kidney.pub/CJASN0834#ASNCJASN: